Actualités et vidéos - HAMILTON THORNE LTD ORD

BEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2023. Financial Highlights Sales for the year increased 16% to $67.2 million; sales for the quarter increased 12% to $18.4...

BEVERLY, Mass. and TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and twelve months ended December 31, 2023 before market open on Wednesday, March 27, 2024. The press release, with accompanying financial...

BEVERLY, Mass. and TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the appointment, of Dr. Ekaterina (Kate) Torchilin as its new President and Chief Executive Officer, effective January 15, 2024. Dr. Torchilin is succeeding David Wolf, who is retiring as President and CEO. Mr. Wolf will...

BEVERLY, Mass. and TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and nine months ended September 30, 2023. Financial Highlights Sales increased 16% year over year to $15.7 million for the quarter; sales for the nine-month period increased 17% to...

BEVERLY, Mass. and TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and nine months ended September 30, 2023 before market open on Monday, November 13, 2023. The press release, with accompanying financial information, will be posted on...

Hamilton Thorne Ltd. Opens the Market PR Newswire TORONTO, Sept. 21, 2023 TORONTO , Sept. 21, 2023 /PRNewswire/ - David Wolf , Chairman and Chief Executive Officer, Hamilton Thorne Ltd. (TSX: HTL) joined Dani Lipkin , Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation from TSX Venture Exchange to Toronto Stock Exchange. Hamilton Thorne is a leading global provider of precision instruments, consumables, software and...

BEVERLY, Mass. and TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced its graduation from the TSX Venture Exchange to the Toronto Stock Exchange (TSX) main board, effective September 7, 2023. Hamilton Thorne’s symbol (HTL) will remain unchanged. David Wolf, President and Chief Executive...

TSX Venture Exchange, Hamilton Thorne Ltd., View From The C-Suite PR Newswire TORONTO, Aug. 21, 2023 TORONTO , Aug. 21, 2023 /PRNewswire/ - David Wolf, Chief Executive Officer, Hamilton Thorne Ltd. (TSXV: HTL) shares his Company's story in an interview with TMX Group. The View From The C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current...

BEVERLY, Mass. and TORONTO, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and six months ended June 30, 2023. Financial Highlights Sales increased 15% year over year to $16.4 million for the quarter; sales for the six-month period increased 17% to $33.1...

BEVERLY, Mass. and TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and six months ended June 30, 2023 before market open on Thursday, August 17, 2023. The press release, with accompanying financial information, will be posted on the...

BEVERLY, Mass. and TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial results for the quarter ended March 31, 2023. Financial Highlights 1st quarter sales increased 19% to $16.7 million; sales for the quarter increased 24% on a constant currency basis 1st quarter adjusted EBITDA...

BEVERLY, Mass. and TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months ended March 31, 2023 before market open on Monday, May 15, 2023. The press release, with accompanying financial information, will be posted on the Company’s...

BEVERLY, Mass. and TORONTO, April 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will participate in the Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023. David Wolf, President and CEO and Francesco Fragasso, CFO of Hamilton Thorne Ltd., will represent the...

BEVERLY, Mass. and TORONTO, March 30, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2022. Financial Highlights 2022 sales increased 11% to a record $58.2 million; annual sales increased 19% on a constant currency basis 4th...

BEVERLY, Mass. and TORONTO, March 23, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months and year-ended December 31, 2022 before market open on Thursday, March 30, 2023. The press release, with accompanying financial information, will be...

Revenue of $58.2 million for the year and $16.4 million for the 4 th quarter; Adj. EBITDA of approximately $10.1 million for the year and $3 million for the quarter BEVERLY, Mass. and TORONTO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported preliminary selected unaudited financial results for...

BEVERLY, Mass. and TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") research, and cell biology markets, today announces the passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer of Hamilton Thorne. Diarmaid passed away on January 19 at age 82, at his lab in Beverly, MA, after a...

• Strengthens Hamilton Thorne Footprint in Computer Assisted Semen Analysis (CASA) for the IVF clinic • Significantly expands expertise in artificial intelligence (AI) enabled product offerings • Expands direct sales and support platform for the Hamilton Thorne group’s product portfolio in Europe BEVERLY, Mass. and TORONTO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables,...

BEVERLY, Mass. and TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three- and nine-month periods ended September 30, 2022 before market open on Tuesday, November 22, 2022. The press release, with accompanying financial information, will...

BEVERLY, Mass. and TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will participate in the 6th Annual Lake Steet Capital Markets Best Ideas Growth Conference being held at the Yale Club in New York, NY on September 14, 2022. David Wolf, President and CEO, and Francesco...